Wednesday, May 03, 2006
Real Money Blog
Wait for Buying Cue in Biotech
05/03/2006 2:33 PM
In this article, Cramer does not trust the bounce back in biotech. He mentions the small rebound in DNA and GILD as a temporary condition.
He exclaims: "It can be brutal at the end."
Finally, he suggests waiting for news of a hedge fund going out of business as a possible catalyst to buy into the sector.
05/03/2006 2:33 PM
In this article, Cramer does not trust the bounce back in biotech. He mentions the small rebound in DNA and GILD as a temporary condition.
He exclaims: "It can be brutal at the end."
Finally, he suggests waiting for news of a hedge fund going out of business as a possible catalyst to buy into the sector.
